Signaling pathways of kaempferol-3-neohesperidoside in glycogen synthesis in rat soleus muscle

Biochimie

Volumn 91, Issue 7, 2009, Pages 843-849

  Cazarolli, Luisa Helena ^a   Folador, Poliane ^a   Pizzolatti, Moacir Geraldo ^a   Mena Barreto Silva, Fátima Regina ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Flavonoid; Glycogen; Insulin; Kaempferol 3 neohesperidoside

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIDIABETIC AGENT; BIOHULIN; CALYCULIN A; CARBON 14; GLUCOSE; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3; HUMAN INSULIN; KAEMPFEROL 3 NEOHESPERIDOSIDE; LITHIUM CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 1; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVATION; EXPERIMENTAL ANIMAL; GLYCOGEN SYNTHESIS; MALE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RAT; SIGNAL TRANSDUCTION; SOLEUS MUSCLE; STRUCTURE ANALYSIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADJUVANTS, IMMUNOLOGIC; ANDROSTADIENES; ANIMALS; ENZYME INHIBITORS; FLAVONOIDS; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ANTAGONISTS; KAEMPFEROLS; LITHIUM CHLORIDE; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SKELETAL; OXAZOLES; PROTEIN PHOSPHATASE 1; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 67349150108     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.04.004     Document Type: Article

References (51)

1. Taha C., and Klip A. The insulin signaling pathway. J. Membr. Biol. 169 (1999) 1-12
2. Hei Y.J. Recent progress in insulin signal transduction. J. Pharmacol. Toxicol. Methods 40 (1998) 123-135
3. Srivastava A.K., and Pandey S.K. Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol. Cell. Biochem. 182 (1998) 135-141
4. Silva F.R.M.B., Szpoganicz B., Pizzolatti M.G., Willrich M.A.V., and De Sousa E. Acute effect of Bauhinia forficata on serum glucose levels in normal and alloxan-induced diabetic rats. J. Ethnopharmacol. 83 (2002) 33-37
5. De Sousa E., Zanatta L., Seifriz I., Creczynski-Pasa T.B., Pizzolatti M.G., Szpoganicz B., and Silva F.R.M.B. Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves. J. Nat. Prod. 67 (2004) 829-832
6. Cazarolli L.H., Zanatta L., Jorge A.P., De Sousa E., Horst H., Voehl V.M., Pizzolatti M.G., Szpoganicz B., and Silva F.R.M.B. Follow-up studies on glycosylated flavonoids and their complexes with vanadium: their anti-hyperglycemic potential role in diabetes. Chem. Biol. Interact. 163 (2006) 177-191
7. Jaouhari J.T., Lazrek H.B., and Jana M. The hypoglycemic activity of Zygophyllum gaetulum extracts in alloxan-induced hyperglycemic rats. J. Ethnopharmacol. 69 (2000) 17-20
8. Zareba G., Serradell N., Castañer R., Davies S.L., Prous J., and Mealy N. Phytotherapies for diabetes. Drugs Future 30 (2005) 1253-1282
9. Narváez-Mastache J.M., Garduño-Ramirez M.L., Alvarez L., and Delgado G. Antihyperglycemic activity and chemical constituents of Eysenhardtia platycarpa. J. Nat. Prod. 69 (2006) 1687-1691
10. Mukherjee P.K., Maiti K., Mukherjee K., and Houghton P.J. Leads from Indian medicinal plants with hypoglycemic potentials. J. Ethnopharmacol. 106 (2006) 1-28
11. Anton S., Melville L., and Rena G. Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell. Signal. 19 (2007) 378-383
12. Manach C., and Donovan J.L. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic. Res. 38 (2004) 771-785
13. Cazarolli L.H., Zanatta L., Alberton E.H., Figueiredo M.S.R.B., Folador P., Damazio R.G., Pizzolatti M.G., and Silva F.R.M.B. Flavonoids: prospective drug candidates. Mini Rev. Med. Chem. 8 (2008) 1429-1440
14. Cazarolli L.H., Zanatta L., Alberton E.H., Figueiredo M.S.R.B., Folador P., Damazio R.G., Pizzolatti M.G., and Silva F.R.M.B. Flavonoids: cellular and molecular mechanism of action in glucose homeostasis. Mini Rev. Med. Chem. 8 (2008) 1032-1038
15. Havsteen B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96 (2002) 67-202
16. Ong K.C., and Khoo H.E. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochem. Pharmacol. 51 (1996) 423-429
17. Ong K.C., and Khoo H.E. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci. 67 (2000) 1695-1705
18. Hsu F.L., Liu I.M., Kuo D.H., Chen W.C., Su H.C., and Cheng J.T. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J. Nat. Prod. 66 (2003) 788-792
19. Jorge A.P., Horst H., De Sousa E., Pizzolatti M.G., and Silva F.R.M.B. Insulinomimetic effects of kaempferitrin on glycaemia and on 14C-glucose uptake in rat soleus muscle. Chem. Biol. Interact. 149 (2004) 89-96
20. Pinent M., Bladé M.C., Salvadó M.J., Arola L., and Ardévol A. Metabolic fate of glucose on 3T3-L1 adipocytes treated with grape seed-derived procyanidin extract (GSPE). Comparison with the effects of insulin. J. Agric. Food Chem. 53 (2005) 5932-5935
21. Valsa A.K., Sudheesh S., and Vijayalakshmi N.R. Effect of catechin on carbohydrate metabolism. Indian J. Biochem. Biophys. 34 (1997) 406-408
22. Liu I.M., Liou S.S., Lan T.W., Hsu F.L., and Cheng J.T. Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med. 71 (2005) 617-621
23. Jung U.J., Lee M.K., Jeong K.S., and Choi M.S. The hypoglycemic effects of Hesperidin and Naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 134 (2004) 2499-2503
24. Park S.A., Choi M.S., Cho S.Y., Seo J.S., Jung U.J., Kim M.J., Sung M.K., Park Y.B., and Lee M.K. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 79 (2006) 1207-1213
25. Singh S.N., Vats P., Suri S., Shyam R., Kumria M.M.L., Ranganathan S., and Sridharan K. Effect of an antidiabetic extract of Catharanthus roseus on enzymic activities in streptozotocin induced diabetic rats. J. Ethnopharmacol. 76 (2001) 269-277
26. Zanatta L., De Sousa E., Cazarolli L.H., Cunha A.J., Pizzolatti M.G., Szpoganicz B., and Silva F.R.M.B. Effect of crude extract and fractions from Vitex megapotamica leaves on hyperglycemia in alloxan-diabetic rats. J. Ethnopharmacol. 109 (2007) 151-155
27. Zanatta L., Rosso A., Folador P., Figueiredo M.S.R.B., Pizzolatti M.G., Leite L.D., and Silva F.R.M.B. Insulinomimetic effect of kaempferol 3-neohesperidoside on the rat soleus muscle. J. Nat. Prod. 71 (2008) 532-535
28. Roach P.J. Glycogen and its metabolism. Curr. Mol. Med. 02 (2002) 101-120
29. Brady M.J., and Saltiel A.R. The role of protein phosphatase-1 in insulin action, recent prog. Horm. Res. 56 (2001) 157-173
30. Kucharski C., Schein V., Capp E., and Silva R.S.M. In vitro insulin stimulatory effect on glucose uptake and glycogen synthesis in the gills of the estuarine crab Chasmagnathus granulate. Gen. Comp. Endocrinol. 125 (2002) 256-263
31. Carlsen J., Christiansen K., and Vinten J. Insulin stimulated glycogen synthesis in isolated rat hepatocytes: effect of protein kinase inhibitors. Cell. Signal. 09 (1997) 447-450
32. Syed N.A., and Khandelwal R.L. Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells. Mol. Cell. Biochem. 211 (2000) 123-136
33. Harmon A.W., Paul D.S., and Patel Y.M. MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 287 (2004) 758-766
34. Ferrer J.C., Favre C., Gomis R.R., Fernández-Novell J.M., Garcia-Rocha M., De la Iglesia N., Cid E., and Guinovart J.J. Control of glycogen deposition. FEBS Lett. 546 (2003) 127-132
35. Mora A., Sakamoto K., McManus E.J., and Alessi D.R. Role of PDK1 - PKB - GSK-3 pathway in regulating glycogen synthase and glucose uptake in the heart. FEBS Lett. 579 (2005) 3632-3638
36. Hajduch E., Litherland G.J., and Hundal H.S. Protein kinase B (PKB/Akt) - a key regulator of glucose transport?. FEBS Lett. 492 (2001) 199-203
37. Ueki K., Yamamoto-Honda R., Kaburagi Y., Yamauchi T., Tobe K., Burgering B.M.T., Coffer P.J., Komuro I., Akanuma Y., Yazaki Y., and Kadowaki T. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273 (1998) 5315-5322
38. Hurel S.J., Rochford J.J., Borthwick A.C., Wells A.M., Vandenheede J.R., Turnbull D.M., and Yeaman S.J. Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem. J. 320 (1996) 871-877
39. Oreña S.J., Torchia A.J., and Garofalo R.S. Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes. J. Biol. Chem. 275 (2000) 15765-15772
40. MacAulay K., Hajduch E., Blair A.S., Coghlan M.P., Smith S.A., and Hundal H.S. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase. Eur. J. Biochem. 270 (2003) 3829-3838
41. Ragolia L., and Begum N. Protein phosphatase-1 and insulin action. Mol. Cell. Biochem. 182 (1998) 49-58
42. Acitores A., González N., Sancho V., Valverde I., and Villanueva-Peñacarrillo M.L. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. J. Endocrinol. 180 (2004) 389-398
43. Aggen J.B., Nairn A.C., and Chamberlin R. Regulation of protein phosphatase-1. Chem. Biol. 7 (2000) R13-R23
44. Azpiazu I., Saltiel A.R., DePaoli-Roach A.A., and Lawrence J.C. Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways. J. Biol. Chem. 271 (1996) 5033-5039
45. Dent P., Lavoinne S.N., Caudwell F.B., Watt P., and Cohen P. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348 (1990) 302-308
46. Lazar D.F., Wiese R.J., Brady M.J., Mastick C.C., Waters S.B., Yamauchi K., Pessin J.E., Cuatrecasas P., and Saltiel A.R. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J. Biol. Chem. 270 (1995) 20801-20807
47. Cross D.A.E., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
48. Peak M., Rochford J.J., Borthwick A.C., Yeaman S.J., and Agius L. Signalling pathways involved in the stimulation of glycogen synthesis by insulin in rat hepatocytes. Diabetologia 41 (1998) 16-25
49. Shepherd P.R., Navé B.T., and Siddle K. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem. J. 305 (1995) 25-28
50. Rodríguez-Gil J.E., Guinovart J.J., and Bosch F. Lithium restores glycogen synthesis from glucose in hepatocytes from diabetic rats. Arch. Biochem. Biophys. 301 (1993) 411-415
51. Fernández-Novell J.M., Rodriguez-Gil J.E., Barberà A., and Guinovart J.J. Lithium ions increase hepatic glycogen synthase stability through a proteasome-related mechanism. Arch. Biochem. Biophys. 457 (2007) 29-34